Eye Health Intervention Study in Upper Manhattan

NANot yet recruitingINTERVENTIONAL
Enrollment

5,840

Participants

Timeline

Start Date

April 1, 2026

Primary Completion Date

March 31, 2031

Study Completion Date

March 31, 2031

Conditions
Glaucoma, SuspectDiabetic RetinopathyCataractRefractive ErrorsVision Impairment and Blindness
Interventions
OTHER

Intervention

Participants randomized to the Intervention Arm and referred to ophthalmology will receive assistance from a Study Coordinator with scheduling in-office eye exam appointment and arranging transportation to these appointments over 2 years at either Columbia Ophthalmology, Harlem Hospital, or their own eye care provider.

OTHER

Usual Care

Consented participants randomized to the Usual Care Arm will receive all the basic level of services including the eye health screening, optometric exam if they fail the screening, and eyeglasses at no charge. Those who require referral to ophthalmology will be scheduled for the initial in-office eye exam and their outcomes will be tracked. No additional support will be provided the Usual Care participants during the study. The Usual Care Arm represents a realistic choice currently available for participants following eye health screening.

Trial Locations (1)

10032

Cuimc/Nyph, New York

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Columbia University

OTHER

NCT06112431 - Eye Health Intervention Study in Upper Manhattan | Biotech Hunter | Biotech Hunter